Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Language
Publication year range
1.
Nutrients ; 10(7)2018 Jul 17.
Article in English | MEDLINE | ID: mdl-30018265

ABSTRACT

Cholinergic dysfunction, impaired brain-derived neurotrophic factor and cAMP response element binding protein (BDNF-CREB) signaling are one of the major pathological hallmarks of cognitive impairment. Therefore, improving cholinergic neurotransmission, and regulating the BDNF-CREB pathway by downregulating apoptosis genes is one strategy for inhibiting the etiology of dementia. This study evaluates the potential effects of Stachys sieboldii MIQ (SS) extract against cognitive dysfunction and its underlying mechanisms. SS supplementation for 33 days improved scopolamine-induced memory impairment symptoms in Morris water maze test and Y-maze test. SS reduced the acetylcholineesterase activity and significantly increase acetylcholine and cholineacetyltransferase activity in the brain. In the subsequent mechanism study, SS regulated the mRNA expression level of neuronal plasticity molecules such as (nerve growth factor) NGF, BDNF, CREB, and its downstream molecules such as Bcl-2 and Egr-1 by downregulating the neuronal apoptosis targets in both hippocampus and frontal cortex. Additionally, inward currents caused by SS in hippocampal CA1 neurons was partially blocked by the GABA receptor antagonist picrotoxin (50 µM), suggesting that SS acts on synaptic/extrasynaptic GABAA receptors. These findings indicate that SS may function in a way that is similar to nootropic drugs by inhibiting cholinergic abnormalities, and neuronal apoptosis targets and ultimately increasing the expression of BDNF-CREB.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Dietary Supplements , Memory Disorders/prevention & control , Nootropic Agents/therapeutic use , Plant Extracts/therapeutic use , Stachys/chemistry , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Animals , Brain-Derived Neurotrophic Factor/agonists , Brain-Derived Neurotrophic Factor/genetics , Choline O-Acetyltransferase/chemistry , Choline O-Acetyltransferase/metabolism , Cholinergic Neurons/enzymology , Cholinergic Neurons/metabolism , Cyclic AMP Response Element-Binding Protein/agonists , Cyclic AMP Response Element-Binding Protein/genetics , Ethnopharmacology , Frontal Lobe/enzymology , Frontal Lobe/growth & development , Frontal Lobe/metabolism , Gene Expression Regulation, Developmental , Hippocampus/enzymology , Hippocampus/growth & development , Hippocampus/metabolism , Male , Medicine, Korean Traditional , Memory Disorders/enzymology , Memory Disorders/metabolism , Mice, Inbred ICR , Nerve Tissue Proteins/agonists , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nootropic Agents/administration & dosage , Plant Extracts/administration & dosage , Random Allocation , Rats, Sprague-Dawley , Republic of Korea
2.
Molecules ; 20(12): 22128-36, 2015 Dec 10.
Article in English | MEDLINE | ID: mdl-26690397

ABSTRACT

Limonin, one of the major components in dictamni radicis cortex (DRC), has been shown to play various biological roles in cancer, inflammation, and obesity in many different cell types and tissues. Recently, the odorant-induced signal transduction pathway (OST) has gained attention not only because of its function in the perception of smell but also because of its numerous physiological functions in non-neuronal cells. However, little is known about the effects of limonin and DRC on the OST pathway in non-neuronal cells. We investigated odorant-stimulated increases in Ca(2+) and cAMP, major second messengers in the OST pathway, in non-neuronal 3T3-L1 cells pretreated with limonin and ethanol extracts of DRC. Limonin and the extracts significantly decreased eugenol-induced Ca(2+) and cAMP levels and upregulated phosphorylation of CREB and PKA. Our results demonstrated that limonin and DRC extract inhibit the OST pathway in non-neuronal cells by modulating Ca(2+) and cAMP levels and phosphorylation of CREB.


Subject(s)
Calcium/metabolism , Cyclic AMP/metabolism , Dictamnus/chemistry , Limonins/pharmacology , Plant Roots/chemistry , Signal Transduction/drug effects , 3T3-L1 Cells , Animals , Cyclic AMP Response Element-Binding Protein/agonists , Cyclic AMP Response Element-Binding Protein/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Cyclic AMP-Dependent Protein Kinases/genetics , Cyclic AMP-Dependent Protein Kinases/metabolism , Eugenol/antagonists & inhibitors , Eugenol/pharmacology , Gene Expression Regulation , Limonins/isolation & purification , Mice , Phosphorylation/drug effects , Plant Extracts/chemistry
3.
Int J Toxicol ; 34(3): 274-83, 2015.
Article in English | MEDLINE | ID: mdl-25972379

ABSTRACT

In the present study, the neuroprotective effect of 5-hydroxy-6,7,4'-trimethoxyflavone (flavone 1), a natural flavone, was investigated in comparison with another flavone, 5,7,4'-trihydroxyflavone (flavone 2) on the hippocampus of amyloid beta (Aß)-injected rats. Rats were treated with the 2 flavones (1 mg/kg/d) for 1 week before Aß injection. Seven days after Aß administration, memory function of rats was assessed in a passive avoidance test (PAT). Changes in the levels of mitochondrial transcription factor A (TFAM), peroxisome proliferator-activated receptor γ coactivator 1 α (PGC-1α), phospho-adenosine monophosphate (AMP)-activated protein kinase (pAMPK), AMPK, phospho-cAMP-responsive element-binding protein (CREB), CREB, and nuclear respiratory factor 1 (NRF-1) proteins were determined by Western blot analysis. Our results showed an improvement in memory in rats pretreated with flavonoids. At the molecular level, phosphorylation of CREB, known as the master modulator of memory processes, increased. On the other hand, the level of mitochondrial biogenesis factors, PGC-1α and its downstream molecules NRF-1 and TFAM significantly increased by dietary administration of 2 flavones. In addition, flavone 1 and flavone 2 prevented mitochondrial swelling and mitochondrial membrane potential reduction. Our results provided evidence that flavone 1 is more effective than flavone 2 presumably due to its O-methylated groups. In conclusion, it seems that in addition to classical antioxidant effect, flavones exert part of their protective effects through mitochondrial biogenesis.


Subject(s)
Alzheimer Disease/prevention & control , Dietary Supplements , Disease Models, Animal , Flavones/therapeutic use , Neuroprotective Agents/therapeutic use , Nootropic Agents/therapeutic use , Transcription Factors/agonists , Alzheimer Disease/metabolism , Animals , Avoidance Learning , Behavior, Animal , Cyclic AMP Response Element-Binding Protein/agonists , Cyclic AMP Response Element-Binding Protein/metabolism , Hippocampus/metabolism , Male , Memory , Mitochondrial Dynamics , Mitochondrial Proteins/agonists , Mitochondrial Proteins/metabolism , Nerve Tissue Proteins/agonists , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Phosphorylation , Protein Processing, Post-Translational , Rats, Wistar , Transcription Factors/metabolism
4.
J Nutr Biochem ; 26(9): 921-8, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26007286

ABSTRACT

The activation of sterol regulatory element binding proteins (SREBPs) is regulated by insulin-induced genes 1 and 2 (Insig-1 and Insig-2) and SCAP. We previously reported that feeding R-α-lipoic acid (LA) to Zucker diabetic fatty (ZDF) rats improves severe hypertriglyceridemia. In this study, we investigated the role of cyclic AMP-responsive element binding protein H (CREBH) in the lipid-lowering mechanism of LA and its involvement in the SREBP-1c and Insig pathway. Incubation of McA cells with LA (0.2 mM) or glucose (6 mM) stimulated activation of CREBH. LA treatment further induced mRNA expression of Insig-1 and Insig-2a, but not Insig-2b, in glucose-treated cells. In vivo, feeding LA to obesity-induced hyperlipidemic ZDF rats activated hepatic CREBH and stimulated transcription and translation of Insig-1 and Insig-2a. Activation of CREBH and Insigs induced by LA suppressed processing of SREBP-1c precursor into nuclear SREBP-1c, which subsequently inhibited expression of genes involved in fatty acid synthesis, including FASN, ACC and SCD-1, and reduced triglyceride (TG) contents in both glucose-treated cells and ZDF rat livers. Additionally, LA treatment also decreased abundances of very low density lipoprotein (VLDL)-associated apolipoproteins, apoB100 and apoE, in glucose-treated cells and livers of ZDF rats, leading to decreased secretion of VLDL and improvement of hypertriglyceridemia. This study unveils a novel molecular mechanism whereby LA lowers TG via activation of hepatic CREBH and increased expression of Insig-1 and Insig-2a to inhibit de novo lipogenesis and VLDL secretion. These findings provide novel insight into the therapeutic potential of LA as an anti-hypertriglyceridemia dietary molecule.


Subject(s)
Cyclic AMP Response Element-Binding Protein/agonists , Dietary Supplements , Hepatocytes/enzymology , Hypertriglyceridemia/diet therapy , Hypolipidemic Agents/therapeutic use , Intracellular Signaling Peptides and Proteins/agonists , Membrane Proteins/agonists , Thioctic Acid/therapeutic use , Alternative Splicing , Animals , Cell Line, Tumor , Cyclic AMP Response Element-Binding Protein/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Hepatocytes/metabolism , Hypertriglyceridemia/blood , Hypertriglyceridemia/metabolism , Hypolipidemic Agents/metabolism , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Lipoproteins, VLDL/blood , Lipoproteins, VLDL/metabolism , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Protein Processing, Post-Translational , Random Allocation , Rats, Inbred BUF , Rats, Zucker , Signal Transduction , Sterol Regulatory Element Binding Protein 1/antagonists & inhibitors , Sterol Regulatory Element Binding Protein 1/metabolism , Thioctic Acid/metabolism , Up-Regulation
5.
Pharm Biol ; 51(9): 1188-95, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23767459

ABSTRACT

CONTEXT: Docosahexaenoic acid (DHA) is one of the critical fatty acids for optimal health, which affect the expression of nerve growth factor and brain-derived neurotrophic factor in brain. OBJECTIVE: This study investigates whether DHA supplementation affects lipid peroxidation and activates the glial-derived neurotrophic factor (GDNF)-mitogen-activated protein kinase pathway (MAPK pathway) in hippocampus of natural aged rat. MATERIALS AND METHODS: Rats were randomly divided into four groups; DHA was orally administered at 80 and 160 mg/kg/day to 24-month female rats for 50 days. The antioxidant parameters and GDNF-GDNF family receptor α-1 (GFRα1)-tyrosine-protein kinase receptor (RET)-MAPK-cyclic AMP response element-binding protein (CERB) pathway were assayed in natural aged rat's hippocampus. RESULTS AND DISCUSSION: The results demonstrated that DHA supplementation significantly increased the activities of superoxide dismutase (SOD) by 37.39 and 57.69%, glutathione peroxidase (GSH-Px) by 27.62 and 32.57% decreased TBARS level by 28.49 and 49.05%, respectively, but did not significantly affect catalase (CAT), in hippocampus, when compared with the aged group. DHA supplementation in diet resulted in an increase of DHA level in hippocampus. Furthermore, we found that DHA supplementation markedly increased the levels of GDNF and GFRα1 and the phosphorylation of RET, and led to the activation of the MAPK pathway in hippocampus tissue. CONCLUSION: DHA supplementation can change fatty acids composition, improve antioxidant parameters and activate the GDNF-MAPK pathway in natural aged rat's hippocampus.


Subject(s)
Aging/metabolism , Dietary Supplements , Docosahexaenoic Acids/therapeutic use , Glial Cell Line-Derived Neurotrophic Factor Receptors/biosynthesis , Glial Cell Line-Derived Neurotrophic Factor/agonists , Hippocampus/metabolism , Neuroprotective Agents/therapeutic use , Animals , Cyclic AMP Response Element-Binding Protein/agonists , Cyclic AMP Response Element-Binding Protein/metabolism , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/metabolism , Female , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics , Glial Cell Line-Derived Neurotrophic Factor Receptors/metabolism , Hippocampus/enzymology , Hippocampus/growth & development , Lipid Peroxidation , MAP Kinase Signaling System , Nerve Tissue Proteins/agonists , Nerve Tissue Proteins/metabolism , Neurons/enzymology , Neurons/metabolism , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/metabolism , Oxidative Stress , Oxidoreductases/chemistry , Oxidoreductases/metabolism , Phosphorylation , Protein Processing, Post-Translational , Random Allocation , Rats , Rats, Sprague-Dawley , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL